Skip to main content

Court dismisses class action suit against Mylan regarding EpiPen

Viatris said it will continue to “defend itself vigorously should there be any further proceedings in the case.”
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.